BeOne Medicines (BEIGF) SVP exercises options and sells 341 ADSs
Rhea-AI Filing Summary
BeOne Medicines Ltd. SVP and General Counsel Lee Chan Henry reported a series of routine equity transactions. He exercised options to acquire 4,433 Ordinary Shares at exercise prices of 14.96, 16.41, and 12.23 per share, which converted into 341 American Depositary Shares (ADSs). Each ADS represents 13 Ordinary Shares. He then sold 341 ADSs at 300.00 per ADS in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly holds 318,370 Ordinary Shares, indicating he retains a substantial equity position in the company.
Positive
- None.
Negative
- None.
Insights
Routine option exercises converted to ADSs and sold under a 10b5-1 plan.
SVP and General Counsel Lee Chan Henry exercised options covering 4,433 Ordinary Shares at preset strike prices, receiving 341 American Depositary Shares. The filing notes that each ADS equals 13 Ordinary Shares, clarifying the economic scale of the exercised awards.
He then sold all 341 ADSs at 300.00 per ADS in an open-market transaction made pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. Such pre-planned sales are typically viewed as scheduled liquidity rather than discretionary market timing.
After these transactions, his direct holdings total 318,370 Ordinary Shares. This remaining stake suggests the sale represents only a small portion of his visible equity exposure. Overall, the pattern and disclosed 10b5-1 plan point to routine compensation-related activity, with limited impact on the broader investment thesis.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) | 1,430 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 1,729 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 1,274 | $0.00 | -- |
| Exercise | American Depositary Shares | 110 | $194.47 | $21K |
| Exercise | American Depositary Shares | 133 | $213.32 | $28K |
| Exercise | American Depositary Shares | 98 | $159.03 | $16K |
| Sale | American Depositary Shares | 341 | $300.00 | $102K |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
